BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gigek CO, Calcagno DQ, Rasmussen LT, Santos LC, Leal MF, Wisnieski F, Burbano RR, Lourenço LG, Lopes-Filho GJ, Smith MAC. Genetic variants in gastric cancer: Risks and clinical implications. Exp Mol Pathol 2017;103:101-11. [PMID: 28736214 DOI: 10.1016/j.yexmp.2017.07.004] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Calcagno DQ, Wisnieski F, Mota ERDS, Maia de Sousa SB, Costa da Silva JM, Leal MF, Gigek CO, Santos LC, Rasmussen LT, Assumpção PP, Burbano RR, Smith MA. Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives. Epigenomics 2019;11:349-62. [DOI: 10.2217/epi-2018-0081] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zhu L, Chen W, Li G, Chen H, Liao W, Zhang L, Xiao X. Upregulated RACK1 attenuates gastric cancer cell growth and epithelial-mesenchymal transition via suppressing Wnt/β-catenin signaling. Onco Targets Ther 2019;12:4795-805. [PMID: 31417279 DOI: 10.2147/OTT.S205869] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Azevedo MM, Pina-Vaz C, Baltazar F. Microbes and Cancer: Friends or Faux? Int J Mol Sci 2020;21:E3115. [PMID: 32354115 DOI: 10.3390/ijms21093115] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Wei Q, Gao Y, Qi C, Yuan X, Li J, Xu Q, Luo C, Chen L, Zhuo W, Xu Z, Ying J. Clinicopathological Characteristics and Prognosis of Signet Ring Gastric Cancer: A Population-Based Study. Front Oncol 2021;11:580545. [PMID: 34490073 DOI: 10.3389/fonc.2021.580545] [Reference Citation Analysis]
5 Yu X, Zhang Q, Gao F, Zhang M, Zheng Q, He Y, Guo W. Predictive value of m5C regulatory gene expression in pancreatic adenocarcinoma. Sci Rep 2021;11:17529. [PMID: 34471186 DOI: 10.1038/s41598-021-96470-w] [Reference Citation Analysis]
6 Wu Y, Tian S, Chen Y, Ji M, Qu Y, Hou P. miR-218 inhibits gastric tumorigenesis through regulating Bmi-1/Akt signaling pathway. Pathol Res Pract 2019;215:243-50. [PMID: 30420101 DOI: 10.1016/j.prp.2018.10.031] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dominguez RL, Cherry CB, Estevez-Ordonez D, Mera R, Escamilla V, Pawlita M, Waterboer T, Wilson KT, Peek RM, Tavera G, Williams SM, Gulley ML, Emch M, Morgan DR. Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America. BMC Cancer 2019;19:545. [PMID: 31174492 DOI: 10.1186/s12885-019-5726-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Zhan XY, Zhang Y, Zhai E, Zhu QY, He Y. Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer. PeerJ 2018;6:e4829. [PMID: 29868263 DOI: 10.7717/peerj.4829] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Negovan A, Iancu M, Fülöp E, Bănescu C. Helicobacter pylori and cytokine gene variants as predictors of premalignant gastric lesions. World J Gastroenterol 2019; 25(30): 4105-4124 [PMID: 31435167 DOI: 10.3748/wjg.v25.i30.4105] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
10 Liu S, Liu JW, Sun LP, Gong YH, Xu Q, Jing JJ, Yuan Y. Association of IL10 gene promoter polymorphisms with risks of gastric cancer and atrophic gastritis. J Int Med Res. 2018;46:5155-5166. [PMID: 30205739 DOI: 10.1177/0300060518792785] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Wang L, Li C, Tian J, Liu J, Zhao Y, Yi Y, Zhang Y, Han J, Pan C, Liu S, Deng N, Xian Z, Li G, Zhang X, Liang A. Genome-wide transcriptional analysis of Aristolochia manshuriensis induced gastric carcinoma. Pharm Biol 2020;58:98-106. [PMID: 31957525 DOI: 10.1080/13880209.2019.1710219] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
12 Olesiński T, Lutkowska A, Balcerek A, Sowińska A, Piotrowski P, Trzeciak T, Maj T, Hevelke P, Jagodziński PP. Long noncoding RNA CCAT1 rs67085638 SNP contribution to the progression of gastric cancer in a Polish population. Sci Rep 2021;11:15369. [PMID: 34321511 DOI: 10.1038/s41598-021-94576-9] [Reference Citation Analysis]
13 Zhu J, Deng L, Chen B, Huang W, Lin X, Chen G, Tzeng CM, Ying M, Lu Z. Magnesium-dependent Phosphatase (MDP) 1 is a Potential Suppressor of Gastric Cancer. Curr Cancer Drug Targets 2019;19:817-27. [PMID: 31218958 DOI: 10.2174/1568009619666190620112546] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Repetto O, Maiero S, Magris R, Miolo G, Cozzi MR, Steffan A, Canzonieri V, Cannizzaro R, De Re V. Quantitative Proteomic Approach Targeted to Fibrinogen β Chain in Tissue Gastric Carcinoma. Int J Mol Sci 2018;19:E759. [PMID: 29518939 DOI: 10.3390/ijms19030759] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Gao Y, Wang Y, Wang X, Wang Y, Zhang X, Sun X. TNF-like ligand 1A is associated with progression and prognosis of human gastric cancer. Onco Targets Ther 2019;12:7715-23. [PMID: 31571922 DOI: 10.2147/OTT.S210939] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
16 Ge S, Wang S, Xiang W, Wang L, Zhu Y, Zhu X, Wang X, Zuo L, Jiang C, Li S, Liu M. [Association of adenylate cyclase-associated protein 2 expression with histopathology and long-term prognosis of gastric cancer]. Nan Fang Yi Ke Da Xue Xue Bao 2019;39:1052-8. [PMID: 31640951 DOI: 10.12122/j.issn.1673-4254.2019.09.08] [Reference Citation Analysis]
17 Machlowska J, Pucułek M, Sitarz M, Terlecki P, Maciejewski R, Sitarz R. State of the art for gastric signet ring cell carcinoma: from classification, prognosis, and genomic characteristics to specified treatments. Cancer Manag Res 2019;11:2151-61. [PMID: 30936747 DOI: 10.2147/CMAR.S188622] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 6.3] [Reference Citation Analysis]
18 Pucułek M, Machlowska J, Wierzbicki R, Baj J, Maciejewski R, Sitarz R. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype. Oncotarget 2018;9:31146-62. [PMID: 30123433 DOI: 10.18632/oncotarget.25757] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 4.8] [Reference Citation Analysis]
19 Lin Y, Wang S, Liu S, Lv S, Wang H, Li F. Identification and Verification of Molecular Subtypes with Enhanced Immune Infiltration Based on m6A Regulators in Cutaneous Melanoma. Biomed Res Int 2021;2021:2769689. [PMID: 33490266 DOI: 10.1155/2021/2769689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Rasool KH, Mahmood Alubadi AE, Al-Bayati IFI. The role of Serum Interleukin-4 and Interleukin-6 in Helicobacter pylori-infected patients. Microb Pathog 2021;162:105362. [PMID: 34942310 DOI: 10.1016/j.micpath.2021.105362] [Reference Citation Analysis]